Immunohaematology Research Group at Hudson Institute

Research Group


The Immunohaematology Research group investigates signalling pathways that control homeostasis and function of blood and immune cells in health and disease.

Specific Immunohaematology lab research interests include

  • Defining the roles of the NFκB signalling pathway in lymphocyte development and function
  • Modulation of iron in disorders of ineffective erythropoiesis
  • Targeting the NFκB pathway in haematological neoplasms.
+ Read more

Diseases we research

Research Group Head | Dr George Grigoriadis, Dr Jim Vadolas

Blood cancers are Australia’s third-biggest cause of cancer deaths. My research is focused on signalling pathways that control the function of blood and immune cells to treat blood cancers such as chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL).
Dr George Grigoriadis

Student opportunities

Publication highlights

Our research group is keen to discuss funding opportunities

Support our research